View Older Stories View More Recent Stories
-
Flowers Foods (FLO) PT Raised to $20 at BMO Capital Following Investor Meetings with CFO
-
Financial 15 Split Corp. Completes Overnight Offering of $109,364,400
-
Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences
-
BMO Capital Downgrades TreeHouse Foods (THS) to Market Perform
-
UPDATE: BMO Capital Starts Corporate Capital Trust (CCT) at Market Perform
-
BMO Capital Starts Fortive (FTV) at Outperform, 'Operating at a Higher Level'
-
Tyson (TSN) PT Raised to $89 at BMO Capital on 3Q Report; 'Stellar Beef Packer Margins'
-
J. C. Penney (JCP) PT Raised to $3.25 at BMO Capital on 3Q Report; 'Long-Standing Challenges in Women's Apparel Still Loom'
-
UPDATE: BMO Capital Downgrades Statoil ASA (STO) to Market Perform Citing A Pending Slowdown in 2018 Operations
-
Switch (SWCH) Guidance Looks Conservative - BMO Capital
-
Fine-Tuned Portfolios and Business Models Stand to Help Retailers Adapt to Change, Says Joe McKeska of Elkhorn Real Estate Partners
-
Valeant Pharma (VRX): Raising PT To $17 But Not Rating...Yet - BMO
-
Pfizer (PFE) Should Buy Biogen (BIIB) Instead - BMO
-
Five Prime Therapeutics (FPRX): Buy on Weakness - BMO
-
Incyte (INCY): Thoughts From BMS-986205 Trial Data - BMO
-
BMO Capital Upgrades NVIDIA (NVDA) to Market Perform, 'Our Underperform Call Did Not Work Out'
-
BMO Capital Upgrades The Chefs' Warehouse, Inc (CHEF) to Outperform, 'Executing Well'
-
SpartanNash Company (SPTN) PT Lowered to $22 at BMO Capital
-
Humana (HUM) PT Lowered to $290 at BMO Capital on 3Q Report; 'Increased Competition in Medicare'
-
Coty Inc. (COTY) PT Lowered to $22 at BMO Capital on 1Q18 Report; 'Higher Confidence in Turnaround Story'
-
Amphastar Pharmaceuticals (AMPH) PT Raised to $17 at BMO Capital on 3Q Report; 'Awaiting Execution With Key Pipeline Opportunities'
-
NVIDIA (NVDA) PT Raised to $135 at BMO Capital, Remains Underperform
-
Brandywine Realty Trust Prices $100.0 Million of 3.950% 5-Year Guaranteed Notes and $450.0 Million of 3.950% 10-Year Guaranteed Notes
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Sep 30
-
Sage Therapeutics (SAGE) Hits 'Very Significant Milestone' - BMO
-
Pilgrim's Pride (PPC) PT Raised to $38 at BMO Capital on 3Q Beat; 'Better than Expected Mexican Margins, Strong U.S. Performance'
-
Pacira Pharmaceuticals (PCRX) PT Raised to $39 at BMO Capital on 3Q Report; 'Higher Gross Margin and Lower R&D'
-
Monster Beverage (MNST) PT Raised to $65 at BMO Capital on 3Q Report; 'Sales Momentum Appears to be Broad-Based'
-
Global Payments (GPN) PT Raised to $115 at BMO Capital on 3Q Report; 'Business Model Shines'
-
e.l.f. Beauty, Inc. (ELF): Category Slowdown WeighS on Results - BMO
-
Match Group (MTCH) PT Raised to $35 at BMO Capital
-
B&G Foods Announces Pricing and Upsizing of Public Offering of Senior Notes
-
InflaRx (IFRX) IPO Opens Flat
-
Financial 15 Split Corp. Announces Successful Overnight Offering
-
B&G Foods Announces Public Offering of Senior Notes
-
Osisko Gold Royalties Reports Third Quarter 2017 Results
-
InflaRx Announces Pricing of Initial Public Offering
-
Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
-
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017
-
Financial 15 Split Corp. Announces Overnight Offering
-
Mallinckrodt plc (MNK) PT Slashed to $38 at BMO Capital; Keeps 'Outperform'
-
BMO Capital Starts Optinose (OPTN) at Outperform, Sees Co. As Potential Takeout Target
-
QEP Resources Announces Pricing of Senior Notes
-
QEP Resources Announces $500 Million Senior Notes Offering
-
MPM Holdings Inc. Launches Initial Public Offering
-
Zoetis (ZTS): Solid Quarter, PT To $70 - BMO
-
Arista Networks (ANET): Another Great Quarter, PT To $205 - BMO
-
BMO Capital Downgrades Flowserve Corp. (FLS) to Market Perform Noting Pace Of Recovery Appears To Be Slowing
-
Apple (AAPL) PT Raised to $195 at BMO Capital
-
BMO Capital Downgrades Gildan Activewear (GIL) to Market Perform


